×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [9]
内容类型
期刊论文 [9]
发表日期
2022 [1]
2021 [1]
2020 [4]
2017 [1]
2016 [1]
2012 [1]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共9条,第1-9条
帮助
限定条件
专题:合肥物质科学研究院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Tumor-infiltrating lymphocytes-based subtypes and genomic characteristics of EBV-associated lymphoepithelioma-like carcinoma
期刊论文
JOURNAL OF PATHOLOGY, 2022
作者:
Yin, WenJuan
;
Jin, JiaoYue
;
Bao, Hua
;
Chen, HanLin
;
Wang, CanMing
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/23
lymphoepithelioma-like carcinomas
TILs quantification
classification
whole exome sequencing
targeted therapy
Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder
期刊论文
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 卷号: 6
作者:
Liu, Fatao
;
Li, Yongsheng
;
Ying, Dongjian
;
Qiu, Shimei
;
He, Yong
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2021/04/26
Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth
期刊论文
CANCER LETTERS, 2020, 卷号: 493
作者:
Hu, Lulu
;
Shen, Dachuan
;
Liang, Dapeng
;
Shi, Ji
;
Song, Chunyan
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2020/11/30
Glioblastoma (GBM)
EGFR
EGFRvIII
TRIP13
Osimertinib
Progress on treatment of MET signaling pathway in non-small cell lung cancer
期刊论文
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020
作者:
Yu, Xiaoqing
;
Yu, Sizhe
;
Fan, Yun
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2020/11/26
MET
Dysregulation
Overexpression
Amplification
Non-small cell lung cancer
Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation
期刊论文
ONCOGENE, 2020, 卷号: 39
作者:
Jin, Ying
;
Bao, Hua
;
Le, Xiuning
;
Fan, Xiaojun
;
Tang, Ming
收藏
  |  
浏览/下载:26/0
  |  
提交时间:2020/11/26
Molecular Analysis of Oncogenic Mutations in Resected Margins by Next-Generation Sequencing Predicts Relapse in Non-Small Cell Lung Cancer Patients
期刊论文
ONCOTARGETS AND THERAPY, 2020, 卷号: 13
作者:
Wei, Weitian
;
Li, Xingliang
;
Song, Mengmeng
;
Wang, Changchun
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2020/11/30
lung cancer
gene mutation
surgical margin
next-generation sequencing
Discovery of 1-(4-(4-Amino-3-(4-(2-morpholinoethoxy)-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)phenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea (CHMFL-FLT3-213) as a Highly Potent Type II FLT3 Kinase Inhibitor Capable of Overcoming a Variety of FLT3 Kinase Mutants in FLT3-ITD Positive AML
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 20, 页码: 8407-8424
作者:
Wang, Aoli
;
Li, Xixiang
;
Chen, Cheng
;
Wu, Hong
;
Qi, Ziping
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2019/06/17
Dual Inhibition of AKT/FLT3-ITD by A674563 Overcomes FLT3 Ligand-Induced Drug Resistance in FLT3-ITD positive AML
期刊论文
ONCOTARGET, 2016, 卷号: 7, 期号: 20, 页码: 29131-29142
作者:
Wang, Aoli
;
Wu, Hong
;
Chen, Cheng
;
Hu, Chen
;
Qi, Ziping
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2017/11/16
Acute Myeloid Leukemia
Flt3-itd
Akt
A6745763
Flt3-ligand
The crossregulation between ERK and PI3K signaling pathways determines the tumoricidal efficacy of MEK inhibitor
期刊论文
JOURNAL OF MOLECULAR CELL BIOLOGY, 2012, 卷号: 4
-
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2020/10/26
KINASE KINASE-1/2 INHIBITOR
PHOSPHOINOSITIDE 3-KINASE-GAMMA
ADVANCED CANCERS
LUNG-CANCER
CELL LUNG
PHASE-II
RESISTANCE
ROBUSTNESS
ACTIVATION
MUTATIONS
systems biology
mathematical model
ERK pathway
PI3K pathway
MEK inhibitor
resistance
robustness
biochemical control analysis
©版权所有 ©2017 CSpace - Powered by
CSpace